Sera-Pharma

Sera-Pharma Limited is a UK-based specialty pharmaceutical company that focuses on the development, licensing, and marketing of niche generic and branded medicines. The company operates primarily in the therapeutic areas of endocrinology, oncology, and rheumatology, aiming to provide high-quality treatments for conditions with limited therapeutic options. Sera-Pharma's commercial portfolio includes liothyronine sodium, a key treatment for hypothyroidism. The company utilizes a collaborative business model, partnering with global manufacturers and distributors to bring its products to market while maintaining a strong focus on regulatory compliance and patient access.